Cytokine-Stimulated Human Lung Alveolar Epithelial Cells Release Eotaxin-2 (CCL24) and Eotaxin-3 (CCL26)
Authors:
- 1 February 2005
- journal article
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 25 (2) , 82-91
Abstract
Asthma is a complex inflammatory disease characterized by a prolonged underlying airway inflammation resulting from cytokine-orchestrated signaling between many types of cells, including airway epithelial cells. Trafficking, recruitment, and activation of cells in airway disease are, in part, modulated by the newly discovered CC subfamily of chemokines, eotaxin (CCL11), eotaxin-2 (CCL24) and eotaxin-3 (CCL26), which transduce signals by acting as agonists for the CCR3 receptor. The specific cytokine stimuli that modulate CCL24 and CCL26 release in airway epithelial cells remain poorly defined. Thus, human 549 alveolar type II epithelium-like cells were stimulated singly and with combinations of 1-100 ng/ml tumor necrosis-factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-4, cytokines known to be elevated in the airways of asthmatics. Release of CCL11, CCL24, and CCL26 was quantified by ELISA, and CCR3 receptors monitored by immunocytochemistry and FACS analysis. Results suggest that epithelial cells release CCL11 during the first 24 h of stimulation, in contrast to a significant increase in CCL24 and CCL26 release after 24-48 h of stimulation. Differential release of the eotaxins in response to cytokine combinations was noted. The alveolar type II epithelial cells were found to possess constitutive CCR3 receptors, which increased after proinflammatory cytokine stimulation. The airway epithelium CCR3 receptor/eotaxin ligand signal transduction system may be an important target for development of novel mechanism-based adjunctive therapies designed to interrupt the underlying chronic inflammation in allergic and inflammatory disorders.Keywords
This publication has 45 references indexed in Scilit:
- Eotaxin-3/CCL26 Is a Natural Antagonist for CC Chemokine Receptors 1 and 5Journal of Biological Chemistry, 2004
- The Role of Human Mast Cell-Derived Cytokines in Eosinophil BiologyJournal of Interferon & Cytokine Research, 2004
- ICAM‐1 expression is highly NF‐κB‐dependent in A549 cellsEuropean Journal of Biochemistry, 2004
- Eotaxin-3 is a natural antagonist for CCR2 and exerts a repulsive effect on human monocytesBlood, 2003
- Chemokines in asthma: Cooperative interaction between chemokines and IL-13Journal of Allergy and Clinical Immunology, 2003
- REGULATION OF HUMAN EOTAXIN-3/CCL26 EXPRESSION: MODULATION BY CYTOKINES AND GLUCOCORTICOIDSCytokine, 2002
- Detection of mRNA for Eotaxin-2 and Eotaxin-3 in Human Dermal Fibroblasts and Their Distinct Activation Profile on Human EosinophilsJournal of Investigative Dermatology, 2001
- Cell-Type-Dependent Induction of eotaxin and CCR3 by Ionizing RadiationBiochemical and Biophysical Research Communications, 2000
- Observations on emerging patterns of asthma in our societyJournal of Allergy and Clinical Immunology, 1999
- High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.Journal of Clinical Investigation, 1997